Advanced Biomed Inc.
Advanced Biomed Inc.
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|
Related Party | - | 0 | - | - | - | - | |||||
Assets Current | |||||||||||
Cash | - | 3 | 3 | 3 | 5 | 3 | |||||
Cash And Cash Equivalents At Carrying Value | 3 | - | - | - | 3 | - | |||||
Prepaid Expense And Other Assets Current | 8 | 8 | 3 | 3 | 3 | 0 | |||||
Assets Current | 11 | 11 | 6 | 6 | 8 | 3 | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Intangible Assets Net Excluding Goodwill | - | - | - | - | - | 0 | |||||
Deferred Costs | - | - | - | - | - | 1 | |||||
Finite Lived Intangible Assets Net | - | - | - | - | 0 | - | |||||
Other Assets Noncurrent | 0 | 0 | 0 | 0 | - | - | |||||
Assets Noncurrent | 0 | 0 | 0 | 0 | 1 | 1 | |||||
Assets | 11 | 11 | 6 | 7 | 8 | 5 | |||||
Liabilities Current | |||||||||||
Accounts Payable And Accrued Liabilities Current | 1 | 1 | 3 | 3 | 4 | 4 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | 1 | 1 | 3 | 3 | 4 | 4 | |||||
Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 1 | 1 | 3 | 3 | 4 | 4 | |||||
Stockholders Equity | |||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 22 | 21 | 21 | 21 | 21 | 16 | |||||
Retained Earnings Accumulated Deficit | -13 | -13 | -20 | -19 | -19 | -17 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Stockholders Equity | 9 | 9 | 3 | 3 | 4 | 1 | |||||
Liabilities And Stockholders Equity | 11 | 11 | 6 | 7 | 8 | 5 | |||||
Majority Shareholder | 0 | -0 | 0 | 0 | 0 | 0 | |||||
Corporate Joint Venture | -0 | -1 | 1 | 1 | 0 | 1 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 400 | 400 | 400 | 400 | 400 | 400 | |||||
Common Stock Shares Issued | 1 | 1 | 1 | 1 | 1 | 20 | |||||
Shares Outstanding | 1 | 1 | 1 | 1 | 1 | 20 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -3.39% | -13.08% | -43.83% | -7.08% | -5.21% | 9.79% | -5.23% | 13.41% | 81.82% | - | - | - |
| 2025 | - | - | - | -50.05% | -50.53% | -64.16% | -18.97% | -41.29% | -63.19% | 2.34% | -10.64% | -21.91% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Advanced Biomed Inc. (ADVB) — SEC Financial Statements & Analysis
Advanced Biomed Inc. (ADVB) is a services-medical laboratories company, incorporated in NV. Advanced Biomed Inc. trades on Nasdaq as: ADVB. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Advanced Biomed Inc. reported a Debt-to-Equity ratio of 0.16x, a Price-to-Book (P/B) ratio of 0.64x (TTM), at a market cap of $5.86M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- 0.16x
- P/B TTM
- 0.64x
- Market Cap
- $5.86M
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Advanced Biomed Inc. in?
Advanced Biomed Inc. (ADVB) operates in the Services-Medical Laboratories industry.
What is ADVB's market cap?
Advanced Biomed Inc. (ADVB) has a market capitalization of $5.86M as of 2026-03-31.
What is ADVB's P/E ratio?
Advanced Biomed Inc. (ADVB)'s trailing twelve month P/E ratio is 1.17x as of 2026-03-31.
What exchange does ADVB trade on?
Advanced Biomed Inc. (ADVB) trades on the Nasdaq.
Where is Advanced Biomed Inc. incorporated?
Advanced Biomed Inc. is incorporated in NV.